When was Nucle AI founded?

Nucle AI was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is Nucle AI located?

Nucle AI is headquartered in Chicago, United States.

Who is the current CEO of Nucle AI?

Avi Veidman of Nucle AI. They have also founded 1 company.

How many employees does Nucle AI have?

As of Feb 28, 2026, the latest employee count at Nucle AI is 70.

Is Nucle AI a funded company?

Nucle AI is a funded company, having raised a total of $60M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 05, 2018.

When was the latest funding round of Nucle AI?

Nucle AI's latest funding was a $***** Series B round on Apr 03, 2024, with participation from 1 investor.

Where does Nucle AI rank among its competitors?

Nucle AI ranks 6th amongst 283 active competitors, of which 84 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Scopio Labs, which secured $10M in Jul, 2025.

Who are the top competitors of Nucle AI?

Nucle AI's top competitors include PAIGE, PathAI and Pictor Labs. Among them, Scopio Labs secured the most recent funding round in July, 2025.

Nucle AI - 2026 Company Profile, Team, Funding & Competitors

Nucle AI is a series B company based in Chicago (United States), founded in 2017 by Avi Veidman and Lotan Chorev. It operates as an AI-assisted platform for image analysis. Nucle AI has raised $60M in funding from investors like Debiopharm, Grove Ventures and M Ventures. The company has 283 active competitors, including 84 funded and 16 that have exited. Its top competitors include companies like PAIGE, PathAI and Pictor Labs.

Company Details

AI-assisted platform for image analysis. The platform enables researchers to analyze and predict the tissue and cell architecture from pathology slides. It helps with the discovery of pathology-based spatial biomarkers.

Website: nucleai.ai
Social
Email ID: *****@nucleai.ai

Key Metrics

Founded Year

2017

Location

Chicago, United States

Stage

Series B

Total Funding

$60M in 4 rounds

Latest Funding Round

Series B, Apr 03, 2024, $*****

Investors

Debiopharm & 10 more

Ranked

6^th among 283 active competitors

Employee Count

70 as on Feb 28, 2026

Similar Companies

PAIGE & 319 more

View Nucle AI's full profile

Nucle AI is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Nucleai Inc CIN: 86-1683979 , United States, Active		-	9 (As on Dec 31, 2023)	-

Nucle AI has raised a total funding of $60M over 4 rounds. Its first funding round was on Mar 05, 2018. Its latest funding round was a Series B round on Apr 03, 2024 for $*****. 1 investor participated in its latest round. Nucle AI has 9 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Nucle AI:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 03, 2024	2490116	Series B	1195235	8552996	9417972	5098215
Mar 22, 2022	9414226	Series B	6553255	6898382	2016923	Debiopharm & 3 more
Jul 07, 2020	4480912	Series A	1262304	6719895	Debiopharm	Grove Ventures & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Nucle AI's funding rounds and investors

The founders of Nucle AI are Avi Veidman and Lotan Chorev. Avi Veidman is the CEO of Nucle AI.

Here are the details of Nucle AI's key team members:

Avi Veidman: Co-Founder & CEO of Nucle AI and founder of 1 other company.
Contact Info: 2 email addresses
Lotan Chorev: Co-Founder and VP R&D of Nucle AI.

View details of Nucle AI's Founder profiles and Board Members

Nucle AI's employee count trend

Nucle AI has 70 employees as of Feb 26. Here is Nucle AI's employee count trend over the years:

Uncover Nucle AI's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nucle AI include PAIGE, PathAI and Pictor Labs. Here is the list of Top 10 competitors of Nucle AI, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PAIGE 2018, New York City (United States), Acquired	Developer of AI applications and foundation models for cancer diagnostics	$241M	Goldman Sachs, Casdin Capital & 9 others	71/100
2nd	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, Merck Global Health Innovation Fund ... & 21 others	70/100
3rd	Pictor Labs 2019, Los Angeles (United States), Series B	AI-based solutions for pathological image analysis	$48.8M	Insight Partners, LabCorp & 4 others	64/100
4th	Aignostics 2018, Berlin (Germany), Series B	Provider of AI-driven solutions for drug development and precision medicine	$53.9M	Wellington Partners Venture Capital, Boehringer Ingelheim Venture Fund ... & 9 others	64/100
5th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	MassMutual, Accomplice & 12 others	62/100
6th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	62/100
7th	Proscia 2014, Philadelphia (United States), Series C	Provider of an AI and cloud-based digital pathology solution for cancer diagnosis	$129M	Triangle Peak Partners, Insight Partners ... & 22 others	59/100
8th	Scopio Labs 2014, Tel Aviv (Israel), Series D	Developer of digital imaging platforms for hematology	$125M	OurCrowd, OTV & 15 others	58/100
9th	PreciseDx 2019, New York City (United States), Series B	Provider of an AI-based medical image analysis software for healthcare professionals	$32M	Eventide Asset Management, Merck Global Health Innovation Fund ... & 6 others	58/100
10th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$35.4M	ARUP Laboratories, Zoetis & 1 others	58/100